We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

55 hedge funds and large institutions have $194M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 4

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

62% more funds holding

Funds holding: 34 → 55 (+21)

22% less capital invested

Capital invested by funds: $248M → $194M (-$53.3M)

Holders
55
Holders Change
+21
Holders Change %
+61.76%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
19
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.83M
2
SCM
Suvretta Capital Management
New York
+$3.36M
3
FFM
Fairmount Funds Management
Pennsylvania
+$3.15M
4
SCM
Sio Capital Management
New York
+$2.83M
5
GPP
Great Point Partners
Connecticut
+$1.43M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$4.38M
2
BCP
Berylson Capital Partners
Massachusetts
-$2.97M
3
Franklin Resources
Franklin Resources
California
-$1.7M
4
SFM
Sphera Funds Management
Israel
-$1.1M
5
PA
Perceptive Advisors
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$444K +$596K +79,366 New
Bank of America
27
Bank of America
North Carolina
$441K +$548K +73,085 +1,302%
LP
28
LMR Partners
United Kingdom
$343K +$460K +61,327 New
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$232K +$311K +41,412 New
JP Morgan Chase
30
JP Morgan Chase
New York
$204K +$273K +36,387 New
FWP
31
Firethorn Wealth Partners
Georgia
$178K +$238K +31,700 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$171K +$229K +30,551 New
Charles Schwab
33
Charles Schwab
California
$163K – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$161K – – –
Millennium Management
35
Millennium Management
New York
$135K +$181K +24,187 New
CA
36
Claro Advisors
Massachusetts
$130K +$60K +8,000 +52%
CCP
37
Clarkston Capital Partners
Michigan
$126K +$169K +22,545 New
CS
38
Credit Suisse
Switzerland
$120K +$162K +21,621 New
UBS AM
39
UBS AM
Illinois
$102K +$137K +18,200 New
AI
40
Atom Investors
Texas
$96K +$128K +17,096 New
SPC
41
Sigma Planning Corp
Michigan
$83K -$52.9K -7,050 -32%
MFS
42
Mirabella Financial Services
United Kingdom
$82K +$110K +14,643 New
Victory Capital Management
43
Victory Capital Management
Texas
$66K +$9.43K +1,256 +12%
TRCT
44
Tower Research Capital (TRC)
New York
$46K +$32.3K +4,303 +111%
Wells Fargo
45
Wells Fargo
California
$42K +$8 +1 +0%
Legal & General Group
46
Legal & General Group
United Kingdom
$38K +$51.3K +6,835 New
Morgan Stanley
47
Morgan Stanley
New York
$33K +$18.2K +2,420 +69%
Marshall Wace
48
Marshall Wace
United Kingdom
$27K +$36.5K +4,870 New
PCM
49
Penserra Capital Management
California
$25K +$34.8K +4,631 New
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$23K +$8.28K +1,103 +37%
1
2
3

PNT Hedge Fund Activity: Q4 2021 in Review

55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q4 2021, worth a combined $194M — down 22% from $248M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PNT positions and 4 closed out — a net gain of 21 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $6.83M. The largest seller was Farallon Capital Management, cutting an estimated $4.38M.

  • 55 institutional investors held POINT Biopharma Global Inc. Common Stock (PNT) as of Q4 2021, up from 34 in Q3 2021.
  • Funds reported $194M of POINT Biopharma Global Inc. Common Stock stock for Q4 2021, down 22% quarter-over-quarter.
  • 25 funds opened new POINT Biopharma Global Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +21 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $6.83M added.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q4 2021 was Farallon Capital Management, an estimated $4.38M sold.

Based on aggregated 13F filings for Q4 2021.